Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis (Q46184125)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis
scientific article

    Statements

    Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit